LGALS3 and hepatocellular carcinoma: Shimosegawa et al. [19] reported that in HCC, galectin-3 expression was correlated with histological differentiation and vascular invasion, and that patients who expressed galectin-3 tended to relapse earlier and had poorer overall survival.